Facing the possibility of a health crisis, coupled with the complicated choices in diagnostic and treatment options can be overwhelming. Lima Memorial Health System is committed to bringing revolutionary diagnostic lung cancer technology to the region to greatly impact the fight against cancer. The Foundation has committed to funding the half million dollar investment to bring this lifesaving technology to our community.
Lung cancer is the second most common cancer in both men and women. Most often, lung cancer is diagnosed when symptoms present. At this point, the cancer is at an advanced state with a five-year survival rate of only 15 percent. Each year, more people die from lung cancer than of colon, breast and prostate cancers combined. Finding lung cancer early dramatically improves survival rates.
The game changer came in 2015 when Medicare began recognizing the benefits of a lifesaving lung screening exam with the use of low-dose CT technology. Lima Memorial was the first in the area to offer these exams to our community, knowing that early detection saves lives. Simultaneously, we invested $6.1 million dollars into the Lima Memorial Cancer Institute at the Medical Park, further solidifying our commitment to improve the health and well-being of our community and especially those affected by cancer. We continue to seek cutting-edge technology to aid in the fight against cancer. That’s why this year, with community support, Lima Memorial will introduce new lung diagnostic technology to the region. Similar to GPS (Global Positioning System) technology, this new technology creates a three-dimensional virtual “roadmap” of the lungs from the patient’s CT-scan that enables the physician to steer a unique set of catheters through the lungs to reach the targeted lesions in a minimally invasive manner. Now, lesions that once had to be painfully watched for changes, or accessed through techniques with potentially high complication rates, can be safely and effectively accessed for definitive diagnostic purposes.
As lung cancer screening initiatives increase and we find more suspicious lung nodules, it is especially critical to provide minimally invasive diagnostic options earlier so patients can receive treatment sooner and have better chances of long-term survival. We are at a crucial time where our diagnostic and surgical technologies have advanced to a level where there could be a significant shift in patient outcomes, and many patients will go on to lead long, active and healthy lives after a lung cancer diagnosis, which was almost unheard of even 10 years ago.
Source: American Cancer Society Cancer Facts & Figures 2016. Retrieved from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2016/